Application of sacrococcygeal ice compress based on posterior acoustic pathway damage decrease on focused ultrasound ablation (FUAS): a randomized controlled study

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300068178

Enrollment

Unknown

Registered

2023-02-09

Start date

2023-02-15

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine leiomyoma

Interventions

sacrococcygeal ice compress:Intraoperative and postoperative ice compress on sacrococcygeal region

blank control:none

Eligibility

Sex/Gender

Female

Age

18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Patients with uterine leiomyomas diagnosed by pelvic color Doppler ultrasound and pelvic magnetic resonance, agree to receive FUAS and sacrococcygeal ice compress, no severe systemic diseases, understand the VAS system, informed consent.

Exclusion criteria

Exclusion criteria: Contraindication to FUAS, history of pelvic pain or sacrococcygeal pain, nervous system diseases, do not understand or approve this randomized controlled trial.

Design outcomes

Primary

Measure	Time frame
visual analogue scale,VAS;	—

Secondary

Measure	Time frame
Postoperative pelvic magnetic resonance imaging;	—

Countries

China

Contacts

Public ContactPan yu

Affiliated Hospital of North Sichuan Medical College

574432575@qq.com+86 15328898882

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026